Eli Lilly And reported $13.68B in Current Liabilities for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
ALKERMES ALKS:US $ 452.98M 69.54M
Amgen AMGN:US $ 14842M 257M
Astrazeneca AZN:US $ 23649M 1427M
AstraZeneca AZN:LN 23649M 1427M
Baxter International BAX:US $ 3441M 97M
Biogen BIIB:US $ 4211.6M 864.4M
Bristol Myers Squibb BMY:US $ 21460M 2469M
Catalent CTLT:US $ 1096M 100M
Coherus Biosciences CHRS:US $ 320.35M 33.3M
Drreddys Laboratories RDY:US $ 85902M 5623M
Eli Lilly And LLY:US $ 13682M 1411.2M
Endo International Ordinary Shares ENDP:US $ 1554.27M 145.06M
Gilead Sciences GILD:US $ 10245M 31M
Glaxosmithkline GSK:US $ 22417M 1030M
GlaxoSmithKline GSK:LN 22417M 1030M
Horizon Pharma HZNP:US $ 854.04M 1.23M
JAZZ PHA JAZZ:US $ 735.05M 145.54M
Lannett LCI:US $ 112.28M 21.81M
Medtronic MDT:US $ 7803M 39M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NVS:US $ 29880M 247M
Novartis NOVN:VX SF 29880M 247M
Perrigo Ordinary Shares PRGO:US $ 2003.8M 19.3M
Phibro Animal Health PAHC:US $ 152.59M 11.53M
Prestige Brands PBH:US $ 148.94M 23.89M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Revance Therapeutics RVNC:US $ 65.87M 7.63M
Teva Pharmaceutical Industries TEVA:US $ 11825M 866M
United Therapeutics UTHR:US $ 320M 8.6M
Zoetis ZTS:US $ 1471M 620M